PMGC (ELAB) Stock Price, News & Analysis

Company Overview

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

Key Stats

• Today's Range: $1.96 to $2.15
• 50-Day Range: $2.04 to $3.21
• 52-Week Range: $1.95 to $849.80
• Volume: 117,705 shs
• Average Volume: 378,452 shs
• Market Capitalization: $2.90 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PMGC Stock Analysis - MarketRank™

PMGC scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for PMGC.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of PMGC is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of PMGC is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

PMGC has a P/B Ratio of 0.18. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.29% of the float of PMGC has been sold short.

Short Interest Ratio / Days to Cover

PMGC has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in PMGC has recently decreased by 21.71%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PMGC does not currently pay a dividend.

Dividend Growth

PMGC does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.29% of the float of PMGC has been sold short.

Short Interest Ratio / Days to Cover

PMGC has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in PMGC has recently decreased by 21.71%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.26

News Sentiment

PMGC has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Multi-Sector Conglomerates companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for PMGC this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, PMGC insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.60% of the stock of PMGC is held by insiders.

Percentage Held by Institutions

Only 22.22% of the stock of PMGC is held by institutions.

ELAB Stock Analysis - Frequently Asked Questions

How have ELAB shares performed this year?

PMGC's stock was trading at $16.03 at the beginning of 2025. Since then, ELAB shares have decreased by 86.9% and is now trading at $2.10.
View the best growth stocks for 2025 here.

How were PMGC's earnings last quarter?

PMGC Holdings Inc. (NASDAQ:ELAB) released its quarterly earnings results on Wednesday, May, 14th. The company reported ($2.90) earnings per share for the quarter. PMGC had a negative net margin of 223.41% and a negative trailing twelve-month return on equity of 77.80%.

When did PMGC's stock split?

PMGC's stock reverse split before market open on Monday, March 10th 2025. A 1-7 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, March 9th 2025. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

When did PMGC IPO?

PMGC (ELAB) raised $6 million in an initial public offering on Tuesday, November 21st 2023. The company issued 1,500,000 shares at a price of $4.00 per share. Univest Securities acted as the underwriter for the IPO.

How do I buy shares of PMGC?

Shares of ELAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of PMGC own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PMGC investors own include BIOLASE (BIOL), Conduit Pharmaceuticals (CDT), Cyclacel Pharmaceuticals (CYCC), Dare Bioscience (DARE), TRACON Pharmaceuticals (TCON), Tempest Therapeutics (TPST) and 22nd Century Group (XXII).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 6/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Multi-Sector Conglomerates
• Industry: DIVERSIFIED OPS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ELAB
• Previous Symbol: NASDAQ:ELAB
• CIK: 1840563
• Web: elevaiskincare.com
• Phone: 866-794-4940
• Fax: N/A
• Employees: 18
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($433.87)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.25 million
• Net Margins: -223.41%
• Pretax Margin: -505,406.53%
• Return on Equity: -77.80%
• Return on Assets: -59.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.97
• Quick Ratio: 8.97

Sales & Book Value

• Annual Sales: $1.71 million
• Price / Sales: 1.69
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $11.53 per share
• Price / Book: 0.18

Miscellaneous

• Outstanding Shares: 1,380,000
• Free Float: 1,367,000
• Market Cap: $2.90 million
• Optionable: N/A
• Beta: -0.37